Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations
| Brand name | POTASSIUM CHLORIDE |
| Generic name | POTASSIUM CHLORIDE |
| Active ingredient(s) | POTASSIUM CHLORIDE |
| Distributed by / for | Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430 |
| NDC | 68462-357-05 |
| Full product label | Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-05 |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
| Distribution | Nationwide |
| Recall initiated | 2024-05-30 |
| Report date | 2024-07-24 |
| Recall completed | — |
| Recall number | D-0607-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Mahwah NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗